All Stories

  1. Arterial remodelling in smokers and in patients with small airway disease and COPD: Implications for lung physiology and early origins of pulmonary hypertension
  2. Vascular remodelling in IPF patients and its detrimental effect on lung physiology: potential role of endothelial to mesenchymal transition (EndMT)
  3. Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights
  4. Cochrane review update leaves big questions unanswered regarding vaping: implications for medical practitioners
  5. Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial–mesenchymal transition
  6. Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?
  7. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
  8. Mitochondrial dysfunction in macrophages: a key to defective bacterial phagocytosis in COPD
  9. Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis
  10. Autophagy, a potential new target in asthma
  11. Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
  12. Essential need for rethink of COPD airway pathology: implications for new drug approaches for prevention of lung cancer as well as small airway fibrosis
  13. Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease
  14. Airway inflammation and inhaled corticosteroids in COPD
  15. inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
  16. Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction
  17. A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial–mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study